查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1969081

血液净化设备市场：按产品类型、模式、组件、通量、薄膜材质、最终用户和应用分類的全球预测，2026年至2032年

Blood Purification Devices Market by Product Type, Modality, Component, Flux Rate, Membrane Material, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，血液净化设备市场价值将达到 170.4 亿美元，到 2026 年将成长至 180.8 亿美元，到 2032 年将达到 276.6 亿美元，复合年增长率为 7.16%。

主要市场统计数据
基准年 2025 170.4亿美元
预计年份：2026年 180.8亿美元
预测年份 2032 276.6亿美元
复合年增长率 (%) 7.16%

随着临床、商业和技术领域的发展趋势重塑血液净化设备及其在医疗保健中的作用，我们提供了观点的分析。

血液净化设备处于肾臟病学、重症监护和慢性病管理等关键且快速发展的领域的交汇点。日益复杂的临床情况、膜化学和滤芯设计的进步，以及医疗服务模式逐渐分散化的趋势，都重新定义了临床医生和医疗服务提供者开展体外循环和腹膜透析疗法的方式。因此，设备製造商、医院采购团队和居家医疗提供者正在重新思考其产品系列、服务模式和临床证据策略，以满足患者需求，同时确保营运和监管合规性。

薄膜技术、数位化整合和分散式医疗保健的创新正在重新定义血液净化设备的竞争格局和临床路径。

在材料科学、数位健康融合以及不断演进的医疗服务模式的推动下，血液净化领域正经历着变革性的转变。膜技术和吸附技术的创新提高了选择性和动态稳定性，而模组化滤芯系统和一次性平台则简化了临床操作，并降低了交叉感染的风险。同时，製造商正在将感测器和数据分析技术融入血液净化，以实现预测性维护、治疗优化和远端监测。这些进步拓展了血液净化设备的效用，使其超越了传统的治疗管理范畴。

对 2025 年美国关税措施对医疗设备製造商的供应链韧性、采购决策和定价动态的影响进行策略分析。

美国2025年实施的关税措施对製造商、经销商和医疗保健采购商产生了多层次的营运和策略影响。关税压力立即凸显了计算全球供应链服务交付成本的重要性，促使许多公司重新评估其关键组件（例如薄膜、过滤器和精密加工零件）的筹资策略。因此，采购部门正在加快供应商合格审核，优先考虑双重采购，并加强对到岸成本的审查，以确保获利能力和供应的连续性。

将产品模式、临床应用和组件策略与可行的产品组合和商业化优先事项进行整合细分洞察。

在血液净化市场中，优先进行细分有助于明确临床需求、商业性驱动因素和创新之间的交集。根据产品类型，血液透析滤过 (HDF)、血液透析 (HD)、血液滤过 (HF)、血液灌流 (HP)、腹膜透析 (PD) 和血浆置换 (PA) 等治疗方法各自具有不同的工程和临床要求，这些要求会影响设备结构、一次性组件设计和临床培训需求。例如，专注于溶质清除的疗法和专注于免疫调节的疗法需要不同的膜特性和滤芯配置，这会影响製造的复杂性和售后服务模式。

区域市场动态将支付方框架、製造地和临床应用趋势连结起来，从而在世界各地创造了不同的机会。

区域趋势持续影响全球企业发展的需求模式、监管复杂性和竞争格局。在美洲，成熟的支付方环境、居家科技的快速普及以及对临床试验和真实世界证据产生的大力投入，正在推动市场活跃。该地区的医疗服务提供者优先考虑与电子健康记录、远端监测和综合护理路径的整合，这推动了对能够提供可衡量结果和简化工作流程的设备的需求。

竞争考察和策略性企业级洞察突显了产品组合扩展、售后市场策略和合作伙伴模式，这些都推动了差异化和规模化发展。

在血液净化领域，竞争优势越来越依赖产品组合的深度、售后市场的渗透率以及提供整合临床解决方案的能力。主要企业意识到，过滤器、透析液组件和一次性产品是高频需求和临床偏好的主要驱动因素，因此正在拓展业务范围，超越固定资产，开发基于耗材和服务合约的可持续收入来源。同时，各企业也在投资膜技术研发、用于客製化组件的积层製造技术以及嵌入式感测技术，以在性能和生命週期成本方面实现差异化竞争。

为确保血液净化领域的韧性、扩大居家照护和建立可持续的收入来源，製造商和供应商可采取的策略重点。

产业领导者需要采取有计划、优先顺序且分阶段的步骤，以抓住市场机会并降低营运风险。首先，透过认证关键薄膜、过滤器和精密组件的多个来源，并探索本地组装和近岸外包，实现供应链多元化，从而降低关税风险并缩短前置作业时间。其次，加快开发家用和小型院内平台，将简化的使用者介面与远端医疗监测相结合，以扩大服务范围并提高患者依从性。第三，优先投资于临床证据的生成，以证明其在急性肾损伤、慢性肾臟病和脓毒症等关键适应症中的价值，并将医疗设备的性能与可衡量的结果联繫起来，从而提供有助于与支付方谈判的资讯。

采用严谨的混合调查方法，结合对临床医生的访谈、监管分析、供应链映射和实地观察，以检验市场洞察。

本分析的调查方法整合了多方面的证据，以得出可靠且实用的见解。初步调查包括对医疗保健专业人员、采购负责人、医疗设备工程师以及製造和分销机构的高级管理人员进行结构化访谈，以收集有关器械性能、服务期望和采购趋势的第一手观点。这些质性研究结果辅以对监管申报文件、临床试验註册资讯和已发表文献的系统性回顾，并对临床适应症、安全性讯号和疗效比较研究结果进行三角验证。

对关键的临床、商业性和供应链挑战做出综合性结论，从而为血液净化设备领域实现永续竞争优势指明方向。

总之，在材料科学进步、数位融合以及医疗模式转向去中心化的推动下，血液净化设备产业正处于转折点。製造商和供应商面临双重挑战：一方面要不断创新以满足不断变化的临床需求，另一方面要重组供应链和商业模式以应对地缘政治和贸易压力。最成功的企业将使产品设计、临床证据产生和售后服务与医院、透析中心和居家照护机构的需求保持一致，从而创造出能够同时引起支付方和临床医生共鸣的、具有竞争力的价值提案。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 血液净化设备市场：依产品类型划分

  • 血液透析滤过
  • 血液透析
  • 血液过滤
  • 血液灌注
  • 腹膜透析
  • 血浆置换疗法

第九章：血液净化设备市场：依模式划分

  • 家用
  • 设施内部

第十章 血液净化设备市场：依组件划分

  • 透析液
  • 筛选
  • 装置
  • 导管和套管

第十一章 以通量率分類的血液净化设备市场

  • 高通量
  • 低通量

第十二章 按薄膜材料分類的血液净化设备市场

  • 纤维素膜
  • 合成膜

第十三章 血液净化设备市场：依最终用户划分

  • 透析中心
  • 居家医疗设施
  • 医院

第十四章 血液净化设备市场：依应用领域划分

  • 急性肾损伤
  • 自体免疫疾病
  • 慢性肾臟病
  • 败血症

第十五章 血液净化设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 血液净化设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 血液净化设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国血液净化设备市场

第十九章：中国血液净化设备市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bellco SpA
  • Cerus Corporation
  • Cytosorbents Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Jafron Biomedical Co., Ltd.
  • Jafron Biomedical Co., Ltd.
  • Medtronic, Plc
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Terumo Corporation
  • Toray Industries, Inc.
Product Code: MRR-1A1A064C05FC

The Blood Purification Devices Market was valued at USD 17.04 billion in 2025 and is projected to grow to USD 18.08 billion in 2026, with a CAGR of 7.16%, reaching USD 27.66 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 17.04 billion
Estimated Year [2026] USD 18.08 billion
Forecast Year [2032] USD 27.66 billion
CAGR (%) 7.16%

An authoritative orientation to the clinical, commercial, and technological forces reshaping blood purification devices and their role across care settings

Blood purification devices occupy a critical and rapidly evolving intersection of nephrology, intensive care, and chronic disease management. Rising clinical complexity, advances in membrane chemistry and cartridge design, and progressive shifts toward decentralized care have collectively redefined how clinicians and providers approach extracorporeal and peritoneal therapies. As a result, device manufacturers, hospital procurement teams, and home-care providers are reassessing product portfolios, service models, and clinical evidence strategies to meet patient needs while maintaining operational and regulatory compliance.

Clinically, the drivers are clear: improvements in device biocompatibility and operational ease are enabling broader adoption across inpatient and outpatient settings, while digital connectivity and point-of-care monitoring are creating new expectations for interoperability and remote management. Economically, manufacturers must balance capital equipment sales with recurring revenue from consumables and maintenance contracts, and consequently are investing in lifecycle support and aftermarket services. In short, this market is characterized by technological progress, shifting care models, and intensifying focus on patient-centered outcomes, which together create both opportunity and urgency for strategic action.

How innovations in membranes, digital integration, and decentralized care are redefining competitive dynamics and clinical pathways for blood purification devices

The blood purification landscape has undergone transformative shifts driven by materials science, digital health integration, and evolving models of care delivery. Membrane innovations and adsorption technologies have improved selectivity and hemodynamic tolerance, while modular cartridge systems and single-use platforms have simplified point-of-care setup and reduced cross-contamination risk. Concurrently, manufacturers are incorporating sensors and data analytics to enable predictive maintenance, treatment optimization, and remote oversight, which together are elevating device utility beyond traditional therapy administration.

Additionally, care delivery is decentralizing as clinical stakeholders increasingly embrace home-based modalities and outpatient dialysis models to improve patient quality of life and reduce hospital strain. This trend has incentivized the design of compact, user-friendly machines and the development of telemonitoring solutions that support adherence and clinical supervision. Regulatory and reimbursement environments are also evolving to recognize value-based outcomes, prompting companies to place greater emphasis on real-world evidence generation and post-market surveillance. Taken together, these shifts are reshaping competitive dynamics, accelerating partnerships between device firms and digital health providers, and creating differentiated pathways for market entry and scale.

Strategic analysis of how 2025 United States tariff measures have reshaped supply chain resilience, sourcing decisions, and pricing dynamics for device manufacturers

The introduction of United States tariff measures in 2025 has produced a layered set of operational and strategic effects for manufacturers, distributors, and healthcare purchasers. Immediately, tariff pressure has amplified the importance of cost-to-serve calculations across global supply chains, prompting many firms to re-evaluate sourcing strategies for critical components such as membranes, filters, and precision-machined parts. Consequently, procurement teams have accelerated supplier qualification, prioritized dual-sourcing, and increased scrutiny of landed costs to preserve margin and ensure continuity of supply.

In response, several strategic pathways have emerged. Some manufacturers have pursued nearshoring and regional manufacturing hubs to mitigate tariff exposure and compress lead times, while others have invested in automation and process efficiencies to offset incremental import duties. Pricing strategies have become more dynamic, with greater use of contractual clauses that share cost fluctuations between suppliers and buyers. Regulatory compliance and documentation requirements have also intensified, as import tariffs often coincide with more stringent customs reviews and certification checks. Over the medium term, these shifts are likely to encourage vertical integration for critical consumables and accelerate the adoption of local assembly for higher-value systems. Importantly, successful actors will be those that combine tactical cost management with strategic investments in resilience, ensuring clinical supply stability without compromising product innovation.

Integrated segmentation insights that map product modalities, clinical applications, and component strategies to actionable portfolio and commercialization priorities

A segmentation-first view of the blood purification market clarifies where clinical need, commercial traction, and innovation converge. Based on product type, therapies such as hemodiafiltration, hemodialysis, hemofiltration, hemoperfusion, peritoneal dialysis, and plasmapheresis present distinct engineering and clinical requirements that influence device architecture, disposables design, and clinical training needs. For example, therapies focused on solute clearance versus immunomodulation demand different membrane properties and cartridge configurations, which in turn shape manufacturing complexity and aftermarket service models.

Based on end user, adoption patterns differ substantially between dialysis centers, home healthcare facilities, and hospitals; dialysis centers prioritize throughput and ergonomics, home healthcare requires compact footprints and simplified interfaces, and hospitals demand interoperability with critical care monitoring and rapid setup. Based on application, the clinical drivers vary from acute kidney injury and sepsis management to chronic kidney disease and autoimmune disorders, each creating specific performance specifications and evidence requirements. Based on modality, the distinction between home use and in-center determines packaging, remote monitoring capabilities, and training pathways. Based on component, value accrues differently across dialysate, filter, machine, and tubing & cannula, with consumables often underpinning recurring revenue and clinical preference. Based on flux rate, high flux and low flux products target separate clinical indications and influence membrane selection and clinical protocols. Finally, based on membrane material, choices between cellulosic membrane and synthetic membrane options affect biocompatibility, solute clearance profiles, and regulatory pathways. Understanding these intersecting segmentation axes enables targeted product positioning, differentiated pricing strategies, and prioritized investment in clinical evidence for the highest-impact subsegments.

Regional market dynamics that link payer frameworks, manufacturing footprints, and clinical adoption trends to differentiated opportunities across global territories

Regional dynamics continue to shape demand patterns, regulatory complexity, and competitive positioning across the global footprint. In the Americas, market activity is driven by a mature payer landscape, rapid adoption of home-use technologies, and strong investment in clinical trials and real-world evidence generation. Providers in the region emphasize integration with electronic health records, remote monitoring, and bundled care pathways, which fosters demand for devices that deliver measurable outcomes and streamlined workflows.

In Europe, the Middle East & Africa, regulatory heterogeneity and differences in public funding models produce a mosaic of opportunity and constraint. Procurement cycles may be longer and reimbursement pathways more centralized in some markets, while cross-border trade and regional distribution hubs enable specialized manufacturers to scale efficiently. In Asia-Pacific, demographic trends and rising incidence of chronic kidney conditions are driving demand growth alongside a rapidly expanding domestic manufacturing base. Local regulatory agencies are strengthening device oversight and fostering partnerships between multinational firms and regional producers to improve access and lower costs. Across all regions, supply chain resilience, local production capabilities, and tailored clinical support models determine competitive advantage and the speed at which innovations achieve clinical penetration.

Competitive and strategic company-level insights that highlight portfolio expansion, aftermarket strategies, and alliance models driving differentiation and scale

Competitive advantage in the blood purification arena increasingly stems from portfolio depth, aftermarket penetration, and the ability to deliver integrated clinical solutions. Leading firms are expanding beyond capital equipment to develop recurring revenue streams anchored in consumables and service contracts, recognizing that filters, dialysate components, and disposables drive high-frequency demand and clinical preference. At the same time, companies are investing in membrane R&D, additive manufacturing for customized components, and embedded sensing technology to differentiate on both performance and lifecycle cost.

Strategic collaboration is also prominent, with technology partnerships linking device manufacturers to digital health providers for telemonitoring and data analytics, and alliances with clinical centers to generate comparative effectiveness data. Mergers and alliances that enable vertical integration of key consumable supply chains or that broaden geographic reach are common strategic responses to tariff pressures and procurement consolidation. Ultimately, winners will combine clinical credibility, disciplined aftermarket execution, and nimble commercial models that address the distinct needs of hospitals, dialysis centers, and home-care providers.

Actionable strategic priorities for manufacturers and providers to secure resilience, expand home-based care, and build recurring revenue streams in blood purification

Industry leaders must act with deliberate, prioritized steps to capture market opportunities while mitigating operational risk. First, diversify supply chains by qualifying multiple sources for critical membranes, filters, and precision components, and by evaluating regional assembly or nearshoring to reduce tariff exposure and compress lead times. Second, accelerate development of home-use and compact in-center platforms that combine simplified user interfaces with telehealth-enabled monitoring to expand access and improve patient adherence. Third, prioritize investments in clinical evidence generation that demonstrate value in key applications such as acute kidney injury, chronic kidney disease, and sepsis, linking device performance to measurable outcomes that inform payer discussions.

In addition, adopt modular product architectures and standardized interfaces to reduce manufacturing complexity and enable faster product updates. Build predictable recurring revenue through consumables and maintenance services, and design flexible commercial agreements that reflect variable demand and cost pass-throughs. Finally, strengthen post-market surveillance and training programs to support safe adoption, and pursue partnerships with regional distributors and clinical networks to accelerate market entry. By combining these strategic moves, companies can preserve margin, enhance resilience, and position their offerings around clinical utility and total cost of care.

A rigorous mixed-methods research approach combining clinician interviews, regulatory analysis, supply chain mapping, and field observation to validate market insights

The research methodology underpinning this analysis synthesizes multiple evidence streams to produce robust, actionable insights. Primary research included structured interviews with clinicians, procurement officers, biomedical engineers, and senior executives from manufacturing and distribution organizations to capture frontline perspectives on device performance, service expectations, and procurement dynamics. These qualitative inputs were complemented by a systematic review of regulatory filings, clinical trial registries, and published literature to triangulate clinical indications, safety signals, and comparative effectiveness findings.

Supply chain mapping and patent landscape analysis were used to identify critical component dependencies and emerging technology trajectories, while targeted field visits to dialysis centers and home-care environments provided contextual understanding of workflow and patient experience. Throughout, data were cross-validated using multiple independent sources and expert review panels to minimize bias and improve reliability. Limitations include evolving regulatory developments and tariff policies that may shift rapidly; accordingly, the methodology includes scheduled update cycles and scenario analyses to reflect new information and maintain relevance for strategic decision-making.

Concluding synthesis of clinical, commercial, and supply chain imperatives that define the path to durable advantage in blood purification devices

In conclusion, the blood purification device sector is at an inflection point driven by material science advances, digital integration, and a clear migration toward decentralized care. Manufacturers and providers face a dual imperative: innovate to meet evolving clinical expectations while restructuring supply chains and commercial models to withstand geopolitical and trade pressures. The most successful organizations will align product design, clinical evidence generation, and aftermarket services to the needs of hospitals, dialysis centers, and home-care providers, thereby creating defensible value propositions that resonate with payers and clinicians alike.

Looking forward, strategic investments in membrane technology, telemonitoring, and regional manufacturing capacity will determine competitive positioning. By proactively addressing supply chain vulnerabilities, prioritizing modular, patient-centric designs, and committing to real-world evidence programs, stakeholders can convert current disruption into a durable advantage and improve patient access to advanced blood purification therapies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Purification Devices Market, by Product Type

  • 8.1. Hemodiafiltration
  • 8.2. Hemodialysis
  • 8.3. Hemofiltration
  • 8.4. Hemoperfusion
  • 8.5. Peritoneal Dialysis
  • 8.6. Plasmapheresis

9. Blood Purification Devices Market, by Modality

  • 9.1. Home Use
  • 9.2. In-Center

10. Blood Purification Devices Market, by Component

  • 10.1. Dialysate
  • 10.2. Filter
  • 10.3. Machine
  • 10.4. Tubing & Cannula

11. Blood Purification Devices Market, by Flux Rate

  • 11.1. High Flux
  • 11.2. Low Flux

12. Blood Purification Devices Market, by Membrane Material

  • 12.1. Cellulosic Membrane
  • 12.2. Synthetic Membrane

13. Blood Purification Devices Market, by End User

  • 13.1. Dialysis Center
  • 13.2. Home Healthcare Facilities
  • 13.3. Hospital

14. Blood Purification Devices Market, by Application

  • 14.1. Acute Kidney Injury
  • 14.2. Autoimmune Disorders
  • 14.3. Chronic Kidney Disease
  • 14.4. Sepsis

15. Blood Purification Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Blood Purification Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Blood Purification Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Blood Purification Devices Market

19. China Blood Purification Devices Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Asahi Kasei Medical Co., Ltd.
  • 20.6. B. Braun Melsungen AG
  • 20.7. Baxter International Inc.
  • 20.8. Bellco S.p.A.
  • 20.9. Cerus Corporation
  • 20.10. Cytosorbents Corporation
  • 20.11. Fresenius Medical Care AG & Co. KGaA
  • 20.12. Jafron Biomedical Co., Ltd.
  • 20.13. Jafron Biomedical Co., Ltd.
  • 20.14. Medtronic, Plc
  • 20.15. Nikkiso Co., Ltd.
  • 20.16. Nipro Corporation
  • 20.17. Terumo Corporation
  • 20.18. Toray Industries, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD PURIFICATION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD PURIFICATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMODIAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMODIAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMODIAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMOFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMOFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMOFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMOPERFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMOPERFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HEMOPERFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PLASMAPHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PLASMAPHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY PLASMAPHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOME USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOME USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOME USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY IN-CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY IN-CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY IN-CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY DIALYSATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY DIALYSATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY DIALYSATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY FILTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY FILTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY FILTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MACHINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MACHINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MACHINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY TUBING & CANNULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY TUBING & CANNULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY TUBING & CANNULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HIGH FLUX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HIGH FLUX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HIGH FLUX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY LOW FLUX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY LOW FLUX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY LOW FLUX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY CELLULOSIC MEMBRANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY CELLULOSIC MEMBRANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY CELLULOSIC MEMBRANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY SYNTHETIC MEMBRANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY SYNTHETIC MEMBRANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY SYNTHETIC MEMBRANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY DIALYSIS CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY DIALYSIS CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY DIALYSIS CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOME HEALTHCARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOME HEALTHCARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOME HEALTHCARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY ACUTE KIDNEY INJURY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY ACUTE KIDNEY INJURY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY ACUTE KIDNEY INJURY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY SEPSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY SEPSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY SEPSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 155. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 156. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 157. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. GCC BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 179. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 180. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 181. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. G7 BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 187. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 188. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 189. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. NATO BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL BLOOD PURIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY FLUX RATE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA BLOOD PURIFICATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)